Background: There has been concern that the use of isotretinoin to treat acne may lead to depression. To date, research has not conclusively determined if this concern is warranted when contemplating the use of isotretinoin.

Objective: This study investigated the impact of isotretinoin use for patients with acne on mood status. The hypothesis was that an association exists between the use of isotretinoin and the development of depression, aside from acne severity.

Methods: We studied the relationship between isotretinoin and depression using a prospective, controlled, cohort design. The study was conducted in a community dermatology clinic. The exposed cohort consisted of consenting patients who were initiating isotretinoin treatment for acne. Patients were either treated with isotretinoin (Acutaneï) therapy (study group) (N=100) or by oral (N=41) or topical acne therapy (control group) (N=59). The Center for Epidemiologic Studies Depression scale and the Zung Depression Status Inventory were used to assess depression both at baseline and after 2 months of prescribed use of isotretinoin or a control medication (topical or oral antibiotics).

Results: There was no correlation between isotretinoin use and the development of depression, based on either the Centre for Epidemiologic Studies Depression scale (Fisherâs exact test, P=0.497) or Zung Depression Status Inventory (ANOVA; F=1.4, P=0.2).

Conclusion: Isotretinoin does not appear to be associated with the development of depression. Thus, denying patients with significant acne an effective medication for fear of developing depression may not be indicated at this point in time.

Download full-text PDF

Source

Publication Analysis

Top Keywords

development depression
16
depression
12
isotretinoin
10
patients acne
8
isotretinoin development
8
epidemiologic studies
8
studies depression
8
depression scale
8
zung depression
8
depression status
8

Similar Publications

Backgrounds: Memory and emotion are especially vulnerable to psychiatric disorders such as post-traumatic stress disorder (PTSD), which is linked to disruptions in serotonin (5-HT) metabolism. Over 90% of the 5-HT precursor tryptophan (Trp) is metabolized via the Trp-kynurenine (KYN) metabolic pathway, which generates a variety of bioactive molecules. Dysregulation of KYN metabolism, particularly low levels of kynurenic acid (KYNA), appears to be linked to neuropsychiatric disorders.

View Article and Find Full Text PDF

Background/objectives: The study's objective was to determine whether social isolation serves as a mediator in the cross-sectional relationship between food insecurity, both as a short-term and longer-term situation, with resource use and depressive symptoms as outcomes.

Methods: This cross-sectional design study utilized secondary survey data, including 30-day and 12-month food security measured by the U.S.

View Article and Find Full Text PDF

Depression, a serious mental illness, is characterized by high risk, high incidence, persistence, and tendency to relapse, posing a significant burden on global health. The connection between depression and gut microbiota is an emerging field of study in psychiatry and neuroscience. Understanding the gut-brain axis is pivotal for understanding the pathogenesis and treatment of depression.

View Article and Find Full Text PDF

Polymeric dielectrics have garnered significant interest worldwide due to their excellent comprehensive performance. However, developing polymeric dielectric films with high permittivity () and breakdown strength () and low dielectric loss (tan) presents a huge challenge. In this study, amorphous aluminum oxide (AlO, AO) transition interfaces with nanoscale thickness were constructed between titanium oxide (TiO, TO) nanosheets and polyvinylidene fluoride (PVDF) to manufacture composites (PVDF/TO@AO).

View Article and Find Full Text PDF

Depression Recognition Using Daily Wearable-Derived Physiological Data.

Sensors (Basel)

January 2025

Department of Psychological and Cognitive Sciences, Tsinghua University, Beijing 100084, China.

The objective identification of depression using physiological data has emerged as a significant research focus within the field of psychiatry. The advancement of wearable physiological measurement devices has opened new avenues for the identification of individuals with depression in everyday-life contexts. Compared to other objective measurement methods, wearables offer the potential for continuous, unobtrusive monitoring, which can capture subtle physiological changes indicative of depressive states.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!